Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
Clinical trial NCT03747120 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03747120
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2024-11-08
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.